UroVysion And Cystoscopy

UroVysion in combination with cystoscopy offers the best available combination of sensitivity and specificity in the detection of recurrent bladder cancer.




UroVysion delivers 96% specifity

 
Definitions
Sensitivity: a statistical measure of the accuracy of a test, i.e., how likely a test is to label as positive those who have a disease or condition.

Specificity: a statistical measure of the accuracy of a test, i.e., how likely a test is to label as negative those who do not have a disease or condition.

References

  1. Halling et al., AUA Poster 665, 2001.
  2. Halling KC, King W, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. Journal of Urology. 2000; 164:1768-1775.
The UroVysion Bladder Cancer Kit (UroVysion Kit) is designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. Results from the UroVysion Kit are intended for use, in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.